Comparing Alkeran vs Gemcitabine
Alkeran | Gemcitabine |
|
---|
Alkeran (melphalan) | Gemcitabine |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Myeloma, Ovarian Cancer. Alkeran may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pancreatic Cancer, Non Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer - Metastatic, Nasopharyngeal Carcinoma, Breast Cancer. gemcitabine may also be used for purposes not listed... View more |
Related suggestions Ovarian Cancer
|
|||||||
More about Alkeran (melphalan) | More about Gemcitabine | ||||||||
Ratings & Reviews | |||||||||
Be the first to share your experience with this drug. |
Gemcitabine has an average rating of 8.0 out of 10 from a total of 7 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Alkeran side effects in more detail. |
See also: gemcitabine side effects in more detail. |
||||||||
Generic Availability | |||||||||
Lower cost generic approved |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all gemcitabine prices |
||||||||
Dosage Forms Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other melphalan brands include: Evomela, Hepzato | Gemzar, Infugem | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
1.5 hours |
10.5 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 263 drugs are known to interact with Alkeran:
|
A total of 267 drugs are known to interact with gemcitabine:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
January 17, 1964 |
May 15, 1996 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.